Abstract
Failure to successfully extinguish fear is a hallmark of trauma-related disorders, like posttraumatic stress disorder (PTSD). PTSD is also characterized by dysfunctional corticolimbic activation and connectivity. The endocannabinoid system is a putative system to target for rescuing these behavioral and neural deficits. In healthy adults, acute, low-dose delta-9-tetrahydrocannabinol (THC) facilitates fear extinction and increases cortico-limbic activation and connectivity in response to threat. The present study determines the effect of acute, low-dose THC on fear-related brain activation and connectivity during fear extinction in trauma-exposed adults with (PTSD = 19) and without PTSD [trauma-exposed controls (TEC) = 26] and non-trauma-exposed [healthy controls (HC) = 26]. We used a Pavlovian fear conditioning and extinction paradigm, where we measured concurrent functional magnetic resonance imaging (fMRI) and behavioral responses (i.e., skin conductance responding and expectancy ratings). Using a randomized, double-blind, placebo-controlled design, N = 71 subjects were randomized to receive placebo (PBO, n = 37) or THC (n = 34) prior to fear extinction learning. During early extinction learning, individuals with PTSD given THC had greater vmPFC activation than their TEC counterparts. During a test of the return of fear (i.e., renewal), HC and individuals with PTSD given THC had greater vmPFC activation compared to TEC. Individuals with PTSD given THC also had greater amygdala activation compared to those given PBO. We found no effects of trauma group or THC on behavioral fear indices during extinction learning, recall, and fear renewal. These data suggest that low dose, oral THC can affect neural indices of fear learning and memory in adults with trauma-exposure; this may be beneficial for future therapeutic interventions seeking to improve fear extinction learning and memory.
Keywords: PTSD, THC, amygdala, fMRI, fear conditioning, prefrontal cortex
Copyright © 2023. Published by Elsevier Inc.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Cannabinoid modulation of corticolimbic activation to threat in trauma-exposed adults: a preliminary study.Psychopharmacology (Berl). 2020 Jun;237(6):1813-1826. doi: 10.1007/s00213-020-05499-8. Epub 2020 Mar 11.PMID: 32162103 Free PMC article. Clinical Trial.
-
Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans.Neurobiol Learn Mem. 2014 Sep;113:125-34. doi: 10.1016/j.nlm.2013.09.009. Epub 2013 Sep 19.PMID: 24055595 Free PMC article. Clinical Trial.
-
Cannabinoid modulation of brain activation during volitional regulation of negative affect in trauma-exposed adults.Neuropharmacology. 2022 Nov 1;218:109222. doi: 10.1016/j.neuropharm.2022.109222. Epub 2022 Aug 15.PMID: 35981598 Clinical Trial.
-
Effects of ∆9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies.BMC Psychiatry. 2020 Aug 26;20(1):420. doi: 10.1186/s12888-020-02813-8.PMID: 32842985 Free PMC article. Review.
-
A review of hippocampal activation in post-traumatic stress disorder.Psychophysiology. 2020 Jan;57(1):e13357. doi: 10.1111/psyp.13357. Epub 2019 Mar 4.PMID: 30829407 Review.